دورية أكاديمية

P1.25-16 Outcomes by Age with Neoadjuvant Atezolizumab Treatment for Resectable Non-small Cell Lung Cancer in the Phase 2 LCMC3 Study.

التفاصيل البيبلوغرافية
العنوان: P1.25-16 Outcomes by Age with Neoadjuvant Atezolizumab Treatment for Resectable Non-small Cell Lung Cancer in the Phase 2 LCMC3 Study.
المؤلفون: Presley, C., Owen, D.H., Nicholas, A., Hilz, S., Oezkan, F., Chaft, J.E., Toloza, E.M., Haura, E.B., Patterson, A., Waqar, S.N., Bunn, P., Johnson, B.E., Kris, M.G., Lee, J.M., Kwiatkowski, D.J., Wistuba, I.I., Schulze, K., Johnson, A., Rusch, V.W., Carbone, D.P.
المصدر: Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS275-S276, 2p
قاعدة البيانات: Complementary Index
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2023.09.470